Department Executive Team
Meredith Irwin, MD
Chair of Paediatrics
Dr. Irwin received her Bachelors of Science at the Massachusetts Institute of Technology and Medical Degree from Harvard Medical School. She completed residency and fellowship training in paediatrics and Haematology/Oncology at Boston Children’s Hospital and Dana-Farber Cancer Institute at Harvard Medical School in Boston, Massachusetts followed by a research fellowship in the laboratory of Dr. William Kaelin, a Howard Hughes Medical Investigator at the Dana-Farber Cancer Institute studying the role of the p53-related genes, p73 and p63, in cancer. After three years on faculty at Dana-Farber Cancer Institute, Dr. Irwin joined the Division of Haematology/Oncology at The Hospital for Sick Children (SickKids) in April 2002 as a Clinician-Scientist.
She is currently a Senior Scientist in Cell Biology, Professor of Paediatrics (cross-appointed to the Departments of Laboratory Medicine and Pathobiology (LMP), Medical Biophysics (MBP)) and the Associate Chair for Paediatrics (Research). She also holds many leadership roles in international committees including the Children’s Oncology Group (COG), International Neuroblastoma Risk Group (INRG), and Advances in Neuroblastoma Research (ANR).
Padmaja Subbarao, MD, M.Sc., FRCP (C)
Associate Chief - Clinical Research, RI
Dr. Padmaja Subbarao is a Clinician-Scientist in Paediatric Respiratory Medicine, specializing clinically in severe asthma. Trained in both Epidemiology and infant and preschool lung function, she holds appointments at the University of Toronto in the Departments of Paediatrics, Physiology and in the Dalla Lana School of Public Health.
Dr. Subbarao’s research program focuses on disentangling preschool wheeze heterogeneity to precisely predict who will develop each type of asthma, monitor its progression and discover the risk factors, exposures and underlying biology associated with each asthma subtype. She is the Director of the CHILD cohort study, one of the largest, most intensively characterized asthma birth cohorts in the world. This world-leading study enabled the discovery of the importance of the gut microbiome for the protection against asthma (cited more than 500 times).
She also established the first infant lung function laboratory in Canada and her early work on the novel multiple breath washout (MBW) lung test helped pave the way for its acceptance by the Federal Drug Agency as an objective outcome measure for clinical trials in Cystic Fibrosis (CF). Her research in early life lung function and risk factors in asthma have enabled the earlier, precise prediction of asthma and monitoring of its progression, thus advancing the diagnosis and treatment of children with asthma.
Angela Punnett, MD, FRCPC
Associate Chair - Education (Interim)
Dr. Punnett is a Staff Oncologist within the Leukemia/Lymphoma Program in the Division of Haematology/Oncology and Associate Professor in Paediatrics at the University of Toronto. She is a Clinician Educator and current Director of Undergraduate Medical Education for Paediatrics at the University of Toronto. Dr. Punnett completed MD at the University of Toronto and Paediatrics Residency at the University of Michigan, Ann Arbor. She returned to the University of Toronto for fellowship training in Paediatric Haematology/Oncology at SickKids.
email: angela.punnett@sickkids.ca
Jeremy Friedman, MB. ChB FRCPC
Associate Chair - Clinical
Dr. Jeremy Friedman graduated from the University of Cape Town in 1985. After completing his internship in South Africa he worked as a family doctor in rural Saskatchewan for 3 years. He began his residency at Sickkids in Toronto in 1990 and finished as chief paediatric resident in 1994. Since then he has worked as fulltime faculty at Sickkids as a general paediatric hospitalist, including as Division Head of Paediatric Medicine from 2004-2014. In 2012 he was appointed Associate Paediatrician-in-Chief at Sickkids and Professor and Associate Chair in the Department of Paediatrics at the University of Toronto. He has previously served as MSA President and is currently co-chair of the hospital MAC as well as interim Paediatrician-in-Chief at Sickkids and Chair of the Department of Paediatrics at the University of Toronto.
Dr Friedman’s academic interests relate to the care provided to the hospitalized child. He is an academic leader in the rapidly growing field of Hospitalist Paediatrics, and introduced the highly regarded Sickkids ‘complex care’ program which has developed into a world leader in care for the medically complex child. A current area of focus relates to resource stewardship and overuse of tests and therapies, where he leads the Sickkids Choosing Wisely initiative. He has consulted broadly to childrens hospitals in Canada and around the world related to models of clinical care.
Dr. Friedman was appointed to the examination board of the Royal College of Physicians and Surgeons for Paediatrics in 2006. He chaired the Canadian Paediatric Society’s Annual Conference 2009-15, and represented hospitalists on the Canadian Paediatric Society’s Acute Care Committee authoring many national clinical guidelines. He has published over 100 manuscripts and book chapters, and has edited two Paediatric handbooks and seven best-selling books for parents sold around the world.
Dr Friedman has been recognized with many awards for his outstanding contributions to clinical care and teaching. He currently acts as the national medical advisor for the Children's Wish Foundation and as a director for the Jacobs Ladder Foundation.
Indra Narang, MEDSCI, MBBCH, FRCPCH, MD
Vice President, Health Equity and Inclusion (Paediatrics Executive Advisory)
Dr. Narang completed medical school and paediatric training in the U.K. She completed her respirology fellowship program at Great Ormond Street Hospital and the Royal Brompton Hospital in London, U.K. Following this, she undertook training in Sleep Medicine at the Children's Hospital of Philadelphia, U.S. Dr. Narang also completed a three-year research degree in paediatric pulmonology and was awarded her Doctor of Medicine (MD research) degree at the University of London. She was appointed as Faculty and the Director of Sleep Medicine at The Hospital for Sick Children (SickKids) in 2007.
Dr. Narang’s ultimate research goal is to advance clinical care and reduce morbidity related to sleep disorders in both healthy children and children with underlying co-morbidities. Currently, Dr. Narang’s research focuses on identifying children with obesity most at risk for obstructive sleep apnea (OSA) and their neurocognitive, metabolic, and cardiovascular outcomes. This research is being undertaken as part of the wider Canadian Sleep and Circadian Network (CSCN) funded by CIHR, for which Dr. Narang is the paediatric lead member (www.cscnweb.ca). Dr. Narang, along with Dr. Andrea Kassner, is also evaluating cerebrovascular injury and related adverse neurocognition using brain MRI in obese youth with OSA (funded by Heart and Stroke Foundation).
Annie Huang, MD, PhD, FRCP (C)
Associate Chair - Research
Dr. Huang is a paediatric neuro-oncologist and scientist with the Cell Biology Research Program, and the Arthur and Sonia Labatt Brain Tumour Research Centre at SickKids. She holds a Tier 1 Canada Research Chair and is a Professor of Paediatrics with Laboratory Medicine and Pathobiology at the University of Toronto.
She received her PhD and MD at the University of Toronto where she trained in cancer genomics and biology, and clinical oncology. Prior to starting her independent laboratory in 2005, she pursued post-doctoral training with Drs Jeremy Squire and Linda Penn at the Ontario Research Institute.
Chris Carew, MBA
Executive Director, Paediatric Operations
Chris joined the Department of Paediatrics at The Hospital for Sick Children (SickKids) in November 2016 as the Director of Strategy, Finance and Administration.
Chris serves as the strategic administrative, financial and operational partner to the Chair, Department of Paediatrics at the University of Toronto and Paediatrician-in-Chief at SickKids, and is the chief financial steward for the Department of Paediatrics. Chris is responsible for the overall management of the department’s Alternate Funding Plan and also champions a collaborative, participative planning process for the Department of Paediatrics and the University of Toronto including a comprehensive communication system to ensure that all stakeholders have the opportunity for appropriate involvement in and information pertaining to strategic directions.
Previously Chris served as the director of strategy for the Centre for Genetic Medicine at SickKids. In this role, Chris brought together research and clinical leaders through the translation of new genetic knowledge with the goal to improve children’s health outcomes through individualized genetic medicine and research while building a more integrated service delivery model for genetics across Ontario.
Prior to joining SickKids in 2007, Chris held senior positions as Executive Director of the Grand River District Health Council and most recently as the Chief Executive Officer leading provincial planning and research initiatives for the Learning Disabilities Association of Ontario.
Chris completed his Master of Business Administration from Royal Roads University in Victoria British Columbia, a Master in Project Management from Schulich School of Business at York University, and is a Scholarship recipient of Schulich’s Business Executive Program from York University in Toronto Ontario.